Industry

Pharmaceuticals

Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.

Total Companies
1 284
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Eli Lilly and Co
NYSE:LLY
Loading...
58% Overvalued
76 / 100
68 / 100
$955.1B
Dechra Pharmaceuticals PLC
LSE:DPH
Loading...
N/A
43 / 100
52 / 100
$586.8B
Johnson & Johnson
NYSE:JNJ
Loading...
14% Overvalued
63 / 100
55 / 100
$486B
Roche Holding AG
SIX:ROG
Loading...
29% Undervalued
64 / 100
66 / 100
$310.1B
AstraZeneca PLC
LSE:AZN
Loading...
10% Undervalued
60 / 100
50 / 100
$280.3B
Novartis AG
SIX:NOVN
Loading...
5% Undervalued
64 / 100
66 / 100
$256.9B
Merck & Co Inc
NYSE:MRK
Loading...
20% Undervalued
66 / 100
68 / 100
$248.1B
Novo Nordisk A/S
CSE:NOVO B
Loading...
38% Undervalued
74 / 100
70 / 100
$216.5B
Pfizer Inc
NYSE:PFE
Loading...
16% Undervalued
51 / 100
45 / 100
$147.2B
Sanofi SA
PAR:SAN
Loading...
45% Undervalued
57 / 100
45 / 100
$120.8B
Bristol-Myers Squibb Co
NYSE:BMY
Loading...
28% Undervalued
60 / 100
40 / 100
$105.6B
GlaxoSmithKline PLC
LSE:GSK
Loading...
6% Undervalued
65 / 100
48 / 100
$97B
Chugai Pharmaceutical Co Ltd
TSE:4519
Loading...
48% Overvalued
64 / 100
93 / 100
$87.4B
Merck KGaA
XETRA:MRK
Loading...
12% Undervalued
51 / 100
56 / 100
$61.4B
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Loading...
22% Overvalued
61 / 100
80 / 100
$57.8B
Zoetis Inc
NYSE:ZTS
Loading...
7% Undervalued
72 / 100
65 / 100
$53.2B
Ucb SA
XBRU:UCB
Loading...
3% Overvalued
55 / 100
72 / 100
$53.1B
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Loading...
27% Overvalued
59 / 100
96 / 100
$48.2B
Takeda Pharmaceutical Co Ltd
TSE:4502
Loading...
17% Undervalued
45 / 100
36 / 100
$44.9B
A
Aspen Pharmacare Holdings Ltd
JSE:APN
Loading...
N/A
46 / 100
43 / 100
$41.6B
Load More